Diabetes Monitoring Devices Market Analysis And Growth Rate to 2028 With Market Players | Medtronic, Dexcom, Sanofi, Abbott Laboratories,

Increasing Prevalence of Diabetes to Augment Growth of Diabetes Monitoring Devices Market

The global diabetes monitoring devices market is estimated to be valued at US$ 15,276.1 million in 2016 and is expected to exhibit a CAGR of 8.87% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Diabetes monitoring devices are medical devices used to monitor blood glucose on a continual basis. These devices/monitors are particularly suitable for people with type I and II diabetes. They work by analyzing a small amount of blood, usually from fingertip, to measure the blood glucose level at that moment. Diabetes monitoring devices are often used in clinics, hospitals, and other surgical centers. These devices also facilitate in delivery of insulin into the patient's body. Moreover, the regular monitoring of diabetes improves outcomes and helps in adjusting treatment in real-time. Moreover, regular blood sugar monitoring is the most important thing one can do to manage type I and/or type II diabetes.

𝐓𝐨 𝐠𝐞𝐭 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 @ https://www.coherentmarketinsights.com/insight/request-sample/1278

Competitive Landscape:

Major players operating in the global diabetes monitoring devices market are Cnoga Medical, MediWise, Sanofi, Dexcom, Medtronic, Bigfoot Biomedical, Abbott Laboratories, and Bayer Healthcare AG, among others.

Key Market Drivers:

Increasing prevalence of diabetes across the globe is expected to propel growth of the diabetes monitoring devices market over the forecast period. For instance, according to the International Diabetes Federation, around 537 million people (aged 20 to 79 years) are living with diabetes, and the number is expected to reach 643 million by 2030 and 783 million by 2045.

Moreover, increasing demand for or adoption of diabetes monitoring devices around the world is expected to boost growth of the diabetes monitoring devices market. For instance, in March 2021, Roche announced the launch of the new Accu-Chek Instant system, which supports and enables Roche's approach of integrated Personalized Diabetes Management (iPDM). iPDM is holistic, patient-centered therapeutic approach with the ultimate goal of personalizing diabetes management to streamline care and improve clinical outcomes.

COVID-19 Impact Analysis:

With the increasing prevalence of diabetes, it is critical for patients to regularly monitor their blood glucose levels to avoid an episodes of hyperglycemia or hypoglycemia. According to the American Diabetes Association, people living with diabetes are at a higher risk of developing complications due to COVID-19. Thus, there is an increasing demand for diabetes monitoring devices during the pandemic, driving the growth of the market.

𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/1278

Key Takeaways:

• The diabetes monitoring devices market is expected to exhibit a CAGR of 8.87% over the forecast period due to the introduction of technologically advanced products. For instance, in November 2021, Intuity Medical announced the launch of its POGO Automatic Blood Glucose Monitoring System in the U.S. The device connects via Bluetooth to the Patterns app, which collects glucose data and gives people with diabetes the ability to see glucose trends and share that data with their healthcare providers.

• Among regions, North America and Asia Pacific are expected to witness robust growth in the diabetes monitoring devices market owing to the high prevalence of diabetes, increase in adoption of monitoring devices, increase in awareness among people, and government initiatives undertaken for the prevention of diabetes in these regions.

• For instance, according to the American Diabetes Association, in 2019, around 37.3 million people in the U.S., or 11.3% of US population, had diabetes. Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents.

• Moreover, in August 2021, Smart Meter announced the availability of its iGlucose monitor for managing gestational diabetes; an easy and reliable way to test, monitor, and manage blood glucose levels. According to the CDC, every year, around 2% to 10% of, or 700,000, pregnancies in the U.S. are affected by gestational diabetes.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/promo/buynow/1278

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This release was published on openPR.